PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for July 9, 2008 Subscribe to this News Feed    
 

Americas Watchdog Investigates Digitek

Americas Watchdog's US Drug Watchdog has expanded its national investigation of the drug called Diditek. In April 2008, Actavis Towtowa recalled all lots of Bertek and UDL Laboratories Digitek (digoxin tablets, USP, all strengths) for oral use, due to a manufacturing defect. Since that time many consumers or their families have received notification of the drugs recall. The US Drug Watchdog wants to talk to any consumer who took this drug and suffered any side affects or complications to include death. Consumers who were exposed to this drug can call the US Drug Watchdog at 866-714-6466 anytime.

(PRWEB) July 9, 2008 -- Americas Watchdog's US Drug Watchdog is expanding its national investigation into the drug called Digitek. According to the Food & Drug Administration (FDA), "the Digitek defect could expose users to twice the amount of active ingredient, which could cause serious and even fatal reactions". The best known side affect of this drug is death. If you or a loved one suffered an injury after taking Digitek, the US Drug Watchdog wants to talk with you. A victim or a family member can call the group anytime at 866-714-6466 or visit their web site at Http://USDrugWatchdog.Com

News Image
So What Happened With Digitek?

The Digitek defect could expose users to twice the amount of active ingredient, which could cause serious and even fatal reactions. According to Americas Watchdog, "symptoms could include, an extremely low pulse rate, vision problems, fatigue, death. Many people we have talked with had no idea why a family member or loved one died until they received the recall letter from their pharmacy or health care provider.


What Kind Of Drug Is Digitek?

Digitek is a form of digitalis, a chemical derived from the foxglove plant that has been used as a heart medicine since the 18th century. The medication is sold generically as digoxin by several companies.

According To The FDA

"The Digitek defect could expose users to twice the amount of active ingredient, which could cause serious and even fatal reactions".

Consumers who took this drug can call the US Drug Watchdog at 866-714-6466 or visit their web site at http://USDrugWatchdog.com

So What Happened?

On April 25, 2008 Actavis Towtowa recalled its Digitek tablets because there existed a possibility that tablets with double the appropriate thickness may have been commercially released. The FDA deemed the Digitek recall a Class I recall, meaning that the defective Digitek tables could cause serious health problems or death. Most if not all US consumers have now been told not to take Digitek by their physician or pharmacist. If a family member of a person who was taking Digitek & then died received the recall letter, please call the US Drug Watchdog at 866-714-6466. The recall letters should have been received in early May 2008. The US Drug Watchdog's web site is located at Http://USDrugWatchdog.Com


If a family member died or has suffered other side affects related to the possible use of Digitek Americas Watchdog is available to consumers or their family members 24-7 at 866-714-6466

Americas Watchdog and its US Drug Watchdog is all about consumer protection and corporate fair play.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/VGhpci1TcXVhLUNvdXAtTG92ZS1FbXB0LVNpbmctWmVybw==

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareThis
CONTACT INFORMATION
THOMAS MARTIN
Americas Watchdog
866-714-6466
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Close Move